Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Capecitabine Market
Capecitabine Market Size
- Report ID: GMI6855
- Published Date: Oct 2023
- Report Format: PDF
Capecitabine Market Size
Capecitabine Market size was valued to be USD 408.2 million in 2022 and is expected to reach USD 652.9 million in 2032 with a CAGR of 4.9% from 2023 to 2032 driven by a number of important factors, such as capecitabine has demonstrated significant clinical effectiveness in treating different cancer types over the years. It is particularly valued for its role in adjuvant therapy (post-surgery) and as a component of combination regimens for metastatic disease and hence its proven efficacy drives its use in cancer treatment.
Furthermore, the increasing global population susceptible to various cancer types such as colorectal cancer, breast cancer, and gastric cancer, serves as a significant driver of the capecitabine industry expansion. According to the report published by World Cancer Research Fund International, 2020 saw an estimated 18.1 million cancer cases worldwide, with breast cancers emerging as the most prevalent, contributing 12.5% to the total number of new diagnoses that year.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Capecitabine Market Size in 2022: | USD 408.2 Million |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 4.9% |
| 2032 Value Projection: | USD 652.9 Million |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 162 |
| Tables, Charts & Figures: | 235 |
| Segments covered: | Indication, Synthesis Type, Mode, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Capecitabine is a chemical compound used as the active pharmaceutical ingredients in formulations, particularly in the manufacturing of medications for cancer treatment. As an API, capecitabine is synthesized and formulated as tablets to be administered orally as part of cancer treatment regimens.
Frequently Asked Questions (FAQ) :
Capecitabine Market Scope
